Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cefazolin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Head & Neck 1 Genitourinary 1

Conditions

Infections 1 Bone Neoplasms 1

Interventions

Doxorubicin 40 Radiotherapy 30 Ifosfamide 28 Vincristine 27 Cyclophosphamide 24 Etoposide 20 Imatinib Mesylate 19 Dactinomycin 14 Radiation 13 Filgrastim 11 Temozolomide 9 Sunitinib 9 Trabectedin 8 Methotrexate 8 Specimen Handling 7 Magnetic Resonance Spectroscopy 6 Granulocyte Colony-Stimulating Factor 6 Chemotherapy, Adjuvant 6 pazopanib 5 nilotinib 5 Zoledronic Acid 5 Neoadjuvant Therapy 5 Irinotecan 5 Cisplatin 5 Carboplatin 5 X-Rays 4 Vinorelbine 4 Topotecan 4 Surgical Procedures, Operative 4 Procarbazine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01479283 2021-03-11

PARITY

McMaster University

Phase 3 Completed

Bone Neoplasms, Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡